王承维, 韩仕哲, 张博. 浙江省岱山县食用碘盐与非碘盐地区居民碘营养及患甲状腺疾病情况调查[J]. 疾病监测, 2013, 28(1): 71-75. DOI: 10.3784/j.issn.1003-9961.2013.1.022
引用本文: 王承维, 韩仕哲, 张博. 浙江省岱山县食用碘盐与非碘盐地区居民碘营养及患甲状腺疾病情况调查[J]. 疾病监测, 2013, 28(1): 71-75. DOI: 10.3784/j.issn.1003-9961.2013.1.022
WANG Cheng-wei, HAN Shi-zhe, ZHANG Bo. Survey of iodine level and prevalence of thyroid diseases in residents in areas using iodized salt or non-iodized salt in Daishan, Zhejiang[J]. Disease Surveillance, 2013, 28(1): 71-75. DOI: 10.3784/j.issn.1003-9961.2013.1.022
Citation: WANG Cheng-wei, HAN Shi-zhe, ZHANG Bo. Survey of iodine level and prevalence of thyroid diseases in residents in areas using iodized salt or non-iodized salt in Daishan, Zhejiang[J]. Disease Surveillance, 2013, 28(1): 71-75. DOI: 10.3784/j.issn.1003-9961.2013.1.022

浙江省岱山县食用碘盐与非碘盐地区居民碘营养及患甲状腺疾病情况调查

Survey of iodine level and prevalence of thyroid diseases in residents in areas using iodized salt or non-iodized salt in Daishan, Zhejiang

  • 摘要: 目的 了解浙江省岱山县食用碘盐与非碘盐地区居民碘营养及患甲状腺疾病情况。 方法 2010年7月抽取食用非碘盐的泥峙社区和食用碘盐的倭井潭社区,分别调查483户707人和87户117人,采集两社区水样、家庭盐样,检测水碘、盐碘,采集居民尿样及血样并进行甲状腺B超检查,尿样和血样分别做尿碘和甲状腺功能激素——游离三碘甲状腺原氨酸、游离甲状腺素、三碘甲状腺原氨酸、甲状腺素、血清促甲状腺素(分别是FT3、FT4、T3、T4、TSH)及甲状腺自身抗体——抗甲状腺球蛋白抗体(Thyroglobulin antibody,TGAb)和甲状腺过氧化物酶抗体(Thyroid peroxidase antibody,TPOAb)检测。 结果 水碘中位数17.5 μg/L,环境不缺碘;泥峙社区盐碘均为非碘盐,倭井潭社区合格碘盐率65.38%,碘盐覆盖率为79.49%;泥峙社区居民尿碘中位数117.06 μg/L,低于倭井潭社区的182.57 μg/L;泥峙社区和倭井潭社区居民临床甲亢、亚临床甲亢、临床甲减和亚临床甲减患病率分别为0.28%、0.42%、0.71%和2.97%, 0、0.85%、0.85%和8.55%;经统计亚临床甲减患病率倭井潭社区高于泥峙社区,其他无统计学意义;两社区居民甲状腺结节患病率分别为27.58%和34.19%;居民TPOAb阳性率分别为8.35%和12.82%, TGAb阳性率分别为6.79%和5.13%,差异均无统计学意义。 结论 倭井潭社区居民碘营养处于适宜水平,患甲状腺疾病除亚临床甲减外其他甲状腺疾病与食用非碘盐的泥峙社区差异无统计学意义,反映食用碘盐未造成甲状腺疾病发病增加趋势。泥峙社区食用非碘盐,居民碘营养仅处在适宜的低值,今后应加强食用碘盐宣传,坚持科学补碘策略。

     

    Abstract: Objective To understand the iodine level and prevalence of thyroid diseases in residents in areas using iodized or non-iodized salt in Daishan, Zhejiang province. Methods In July 2010,the survey was conducted in Nizhi community(non-iodized salt area) and in Wojingtan community(iodized salt area). The concentrations of iodine in water samples and in edible salt samples were detected. The detections of urine iodine and blood iodine and B ultrasound examination of thyroid were conducted for 707 people from 483 families in non-iodized salt area and in 117 people from 87 families in iodized salt area. Results The median of iodine in water was 17.5 μg/L. The qualified rate of iodized salt was 65.38% and the coverage rate of iodized salt was 79.49% in iodized salt area. The median of urine iodine concentration in residents in non-iodized salt area was 117.06 μg/L,which was lower that in iodized salt area(182.57 μg/L). The prevalence rates of clinical hyperthyreosis, subclinical hyperthyreosis, clinical hypothyroidism and subclinical hypothyroidism were 0.28%, 0.42%, 0.71% and 2.97% respectively in non-iodized salt area and 0, 0.85%, 0.85% and 8.55% respectively in iodized area. The prevalence rate of subclinical hypothyroidism in iodized salt area was significantly higher that in non-iodized salt area, the differences in other rates had no significance. The prevalence rate of thyroid nodule was 27.58% and 34.19% respectively in two areas, and the TPOAb positive rate was 8.35% and 12.82% respectively, the TGAb positive rate was 6.79% and 5.13% respectively. The differences had no statistical significances. Conclusion The iodine level of the residents in iodized salt area was normal. The differences in the prevalence of thyroid diseases, except subclinical hypothyroidism, had no statistical significances, reflecting that using iodized salt hadn't increase the prevalence of thyroid diseases. The iodized salt coverage and the resident iodine level in non-iodized salt area were at normal but low level. It is necessary to strengthen the promotion of iodized salt using and continue the strategy of reasonable supplement of iodine.

     

/

返回文章
返回